The Life Sciences Report
Notable Quotes
"By the end of 2014, you're going to have some pretty good news flow out of BDSI." (4/24/14) BioDelivery Sciences International Inc. - Charles Duncan, Piper Jaffray & Co. More >
"ARNI's onapristone could legitimately be considered a pipeline in a single product." (4/22/14) Arno Therapeutics Inc. - The Life Sciences Report Interview with Raghuram Selvaraju More >
"THLD's soft-tissue sarcoma study should read out at the end of 2015; that could be a very exciting time." (4/24/14) Threshold Pharmaceuticals Inc. - The Life Sciences Report Interview with Charles Duncan More >
"CUR's science is cutting edge, and of a very high quality." (4/22/14) Neuralstem Inc. - The Life Sciences Report Interview with Raghuram Selvaraju More >
"The Phase 2 trial for VGX-3100 could be a major clinical validation of the power of INO's broadly applicable platform." (4/24/14) Inovio Pharmaceuticals Inc. - Charles Duncan, Piper Jaffray & Co. More >
Companies
| Last: | |||
| Change: | Change(%): | ||
| Volume: | Open: | ||
| High: | Low: | ||
| 52Wk High: | 52Wk Low: | ||
Valeant Pharmaceuticals International Inc.TICKER: VRX:NYSE; VRX:TSX
|